Breast cancer (BC) is a heterogeneous disease with different molecular phenotypes, and a prominent role in breast carcinogenesis is played by 17β-estradiol (E2) signaling, which occurs through the engagement of estrogen receptor α (ERα). Here, ESR1 is linked to breast carcinoma.